Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.
Ashraf GM, Greig NH, Khan TA, Hassan I, Tabrez S, Shakil S, Sheikh IA, Zaidi SK, Akram M, Jabir NR, Firoz CK, Naeem A, Alhazza IM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2014;13(7):1280-93.
Similar articles
Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.
Kamal MA, Priyamvada S, Anbazhagan AN, Jabir NR, Tabrez S, Greig NH.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):338-46. Review.
Alzheimer's and type 2 diabetes treatment via common enzyme targeting.
Jabir NR, Kamal MA, Abuzenadah AM, Gan SH, Alama MN, Baeesa SS, Tabrez S.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):299-304. Review.
A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.
Tabrez S, Jabir NR, Shakil S, Greig NH, Alam Q, Abuzenadah AM, Damanhouri GA, Kamal MA.
CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):395-409. Review.
Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.
Jabir NR, Firoz CK, Baeesa SS, Ashraf GM, Akhtar S, Kamal W, Kamal MA, Tabrez S.
CNS Neurosci Ther. 2015 Jan;21(1):1-7. doi: 10.1111/cns.12344. Epub 2014 Nov 15. Review.
Comparative study of non-high density lipoproteins cholesterol level and lipid profile in pre-diabetic and diabetic patients.
Banu S, Jabir NR, Manjunath NC, Firoz CK, Kamal MA, Khan MS, Tabrez S.
CNS Neurol Disord Drug Targets. 2014 Apr;13(3):402-7.
Interaction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking study.
Shakil S, Khan R, Tabrez S, Alam Q, Jabir NR, Sulaiman MI, Greig NH, Kamal MA.
CNS Neurol Disord Drug Targets. 2011 Nov;10(7):845-8.
Elucidating Treatment of Alzheimer's Disease via Different Receptors.
Ul Islam B, Khan MS, Jabir NR, Kamal MA, Tabrez S.
Curr Top Med Chem. 2017;17(12):1400-1407. doi: 10.2174/1568026617666170103163715. Review.
An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy.
Ashraf GM, Tabrez S, Jabir NR, Firoz CK, Ahmad S, Hassan I, Alexiou A, Kamal MA.
Curr Drug Metab. 2015;16(8):719-27. Review.
Common Therapeutic Modalities Against Diabetes and Associated Cardiovascular Disease.
Jabir NR, Firoz CK, Ashraf GM, Zaidi SK, Shakil S, Kamal MA, Tabrez S.
Curr Vasc Pharmacol. 2017;15(4):365-373. doi: 10.2174/1570161115666170105125034.
An overview on the correlation of neurological disorders with cardiovascular disease.
Firoz CK, Jabir NR, Khan MS, Mahmoud M, Shakil S, Damanhouri GA, Zaidi SK, Tabrez S, Kamal MA.
Saudi J Biol Sci. 2015 Jan;22(1):19-23. doi: 10.1016/j.sjbs.2014.09.003. Epub 2014 Sep 6. Review.
C-peptide and its correlation to parameters of insulin resistance in the metabolic syndrome.
Banu S, Jabir NR, Manjunath CN, Shakil S, Kamal MA.
CNS Neurol Disord Drug Targets. 2011 Dec;10(8):921-7.
Potential Linkage Between Cerebrovascular Diseases and Metabolic Syndrome.
Jabir NR, Firoz CK, Khan MS, Zaidi SK, Ashraf GM, Shakil S, Kamal MA, Tabrez S.
Curr Drug Metab. 2017;18(1):62-68. doi: 10.2174/1389200217666160810155055.
Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients.
Banu S, Jabir NR, Manjunath NC, Khan MS, Ashraf GM, Kamal MA, Tabrez S.
Saudi J Biol Sci. 2015 Jan;22(1):32-6. doi: 10.1016/j.sjbs.2014.04.005. Epub 2014 May 23.
Cardiovascular disease management through restrained inflammatory responses.
Jabir NR, Tabrez S.
Curr Pharm Des. 2016;22(7):940-6. Review.
A Synopsis of Nano-Technological Approaches Toward Anti-Epilepsy Therapy: Present and Future Research Implications.
Jabir NR, Tabrez S, Firoz CK, Zaidi SK, Baeesa SS, Gan SH, Shakil S, Kamal MA.
Curr Drug Metab. 2015;16(5):336-45. Review.
Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases.
Jabir NR, Siddiqui AN, Firoz CK, Ashraf GM, Zaidi SK, Khan MS, Shakil S, Alama MN, Kamal MA, Tabrez S.
Curr Pharm Des. 2016;22(5):566-71. Review.
Altered galectin glycosylation: potential factor for the diagnostics and therapeutics of various cardiovascular and neurological disorders.
Ashraf GM, Perveen A, Tabrez S, Jabir NR, Damanhouri GA, Zaidi SK, Banu N.
Adv Exp Med Biol. 2015;822:67-84. doi: 10.1007/978-3-319-08927-0_10.
Nanotechnology-based approaches in anticancer research.
Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA.
Int J Nanomedicine. 2012;7:4391-408. doi: 10.2147/IJN.S33838. Epub 2012 Aug 9. Review.
Estimation of Interleukin-1β Promoter (-31 C/T and -511 T/C) Polymorphisms and Its Level in Coronary Artery Disease Patients.
Tabrez S, Jabir NR, Firoz CK, Hindawi S, Shakil S, Damanhouri GA, Zaidi SK.
J Cell Biochem. 2017 Sep;118(9):2977-2982. doi: 10.1002/jcb.25958. Epub 2017 Apr 12.
Filters: Manage Filters